Ondine Biomedical Inc. (LON:OBI) Insider Carolyn Cross Buys 200,775 Shares

Ondine Biomedical Inc. (LON:OBI) insider Carolyn Cross acquired 200,775 shares of the business’s stock in a transaction dated Thursday, January 30th. The stock was purchased at an average price of GBX 12 ($0.15) per share, with a total value of £24,093 ($29,601.92).

Ondine Biomedical Stock Performance

LON:OBI opened at GBX 12.21 ($0.15) on Monday. The firm has a market cap of £33.86 million, a PE ratio of -407.03 and a beta of 0.10. Ondine Biomedical Inc. has a fifty-two week low of GBX 4.50 ($0.06) and a fifty-two week high of GBX 13.30 ($0.16). The business has a 50 day moving average price of GBX 9.16 and a 200-day moving average price of GBX 7.98. The company has a debt-to-equity ratio of 1,847.37, a quick ratio of 8.26 and a current ratio of 0.80.

About Ondine Biomedical

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.